Stacy Fuhrmann
- Physiology top 2%
- Adenosine and Purinergic Signaling 2
-
- CAR-T cell therapy research 3
-
- Immune Cell Function and Interaction 2
-
- Monoclonal and Polyclonal Antibodies Research 4
- Radiopharmaceutical Chemistry and Applications 1
-
- Glycosylation and Glycoproteins Research 1
- RNA modifications and cancer 1
-
- Cancer Research and Treatments 1
- Co-authors
- Kathy MulgrewScott A. HammondErin SultKris F. SachsenmeierCarl HayMelissa DamschroderRaymond RothsteinKelly McGlinchey
- Cited by
- PhysiologyOncologyImmunology
- Partner nations
- United StatesRussiaSwitzerland
In The Last Decade
Stacy Fuhrmann
8 papers receiving 382 citations
Peers
Comparison fields: 5 of 52
- Physiology 134
- Oncology 206
- Immunology 158
- Radiology, Nuclear Medicine and Imaging 80
- Biological Psychiatry 5
Countries citing papers authored by Stacy Fuhrmann
This map shows the geographic impact of Stacy Fuhrmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stacy Fuhrmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stacy Fuhrmann more than expected).
Fields of papers citing papers by Stacy Fuhrmann
This network shows the impact of papers produced by Stacy Fuhrmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stacy Fuhrmann. The network helps show where Stacy Fuhrmann may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Stacy Fuhrmann, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 229 | |
| 2 | 2015 | 10 | |
| 3 | 2014 | 71 | |
| 4 | 2010 | 1 | |
| 5 | 2009 | 29 | |
| 6 | Bioavailability, pharmacodynamic activity, and anti-tumor efficacy of the CD19/CD3-specific BiTE antibody MEDI-538 (MT103) delivered subcutaneously in animal models | 2008 | 2 |
| 7 | 2006 | 48 | |
| 8 | 2006 | 1 |
About Stacy Fuhrmann
Stacy Fuhrmann is a scholar working on Physiology, Radiology, Nuclear Medicine and Imaging and Oncology, having authored 8 papers that have together received 391 indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (4 papers), CAR-T cell therapy research (3 papers), Adenosine and Purinergic Signaling (2 papers), Immune Cell Function and Interaction (2 papers), Glycosylation and Glycoproteins Research (1 paper), RNA modifications and cancer (1 paper), Radiopharmaceutical Chemistry and Applications (1 paper) and Cancer Research and Treatments (1 paper). The work is most often cited by research in Physiology (134 citations), Oncology (206 citations) and Immunology (158 citations). Stacy Fuhrmann has collaborated with scholars based in United States, Russia and Switzerland. Frequent co-authors include Kathy Mulgrew, Scott A. Hammond, Erin Sult, Kris F. Sachsenmeier, Carl Hay, Melissa Damschroder, Raymond Rothstein, Kelly McGlinchey, Edmund Poon and Robert E. Hollingsworth. Their work appears in journals such as Blood, Molecular and Cellular Biology and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.